|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.720 USD | -4.97% |
|
+14.67% | -80.95% |
| 05-09 | EnGene Therapeutics Inc. - Special Call | |
| 05-07 | EnGene Therapeutics Inc. Announces Updated Interim Results From Legend Pivotal Cohort | CI |
| Capitalization | 115M 99.15M 90.65M 86.49M 159M 11.05B 161M 1.09B 421M 5.25B 432M 423M 18.28B | P/E ratio 2026 * |
-0.86x | P/E ratio 2027 * | -0.84x |
|---|---|---|---|---|---|
| Enterprise value | -67.77M -58.32M -53.32M -50.87M -93.26M -6.5B -94.8M -640M -248M -3.09B -254M -249M -10.75B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | -3.47x |
| Free-Float |
86.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: enGene Therapeutics Inc.
| 1 day | -4.97% | ||
| 1 week | +14.67% | ||
| Current month | -76.34% | ||
| 1 month | -77.84% | ||
| 3 months | -82.41% | ||
| 6 months | -79.84% | ||
| Current year | -80.95% |
| 1 week | 1.4 |  | 1.82 |
| 1 month | 1.4 | | 9 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 47.17 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 63 | 21/07/2024 |
Anthony Cheung
CTO | Chief Tech/Sci/R&D Officer | 55 | 24/04/2023 |
Ryan Daws
DFI | Director of Finance/CFO | 52 | 27/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerry Brunk
BRD | Director/Board Member | 57 | 08/08/2023 |
Richard Glickman
CHM | Chairman | 67 | 15/05/2024 |
Lota Zoth
BRD | Director/Board Member | 66 | 18/12/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.97% | +14.67% | -49.41% | -83.68% | 115M | |
| -0.14% | +3.34% | +42.69% | +84.71% | 50.1B | |
| +0.12% | -3.44% | +67.99% | +49.40% | 45.82B | |
| -5.60% | +7.69% | +62.36% | +466.37% | 23.66B | |
| -2.65% | -4.86% | -3.02% | -17.01% | 22.65B | |
| +3.19% | +3.12% | +41.22% | -27.18% | 17.8B | |
| -1.66% | +2.59% | +30.04% | -41.59% | 16.08B | |
| -2.91% | -10.30% | +47.85% | +186.19% | 14.14B | |
| -7.00% | -6.69% | -26.94% | +821.86% | 13.09B | |
| +0.41% | -2.37% | +40.93% | - | 13B | |
| Average | -2.12% | -0.46% | +25.37% | +159.90% | 21.64B | |
| Weighted average by Cap. | -1.35% | -1.30% | +40.32% | +144.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 7.92M 6.81M 6.23M 5.94M 10.9M 760M 11.08M 74.74M 28.92M 361M 29.71M 29.08M 1.26B |
| Net income | -135M -116M -106M -102M -186M -12.99B -189M -1.28B -494M -6.16B -508M -497M -21.48B | -154M -133M -121M -116M -212M -14.77B -215M -1.45B -562M -7.01B -578M -566M -24.44B |
| Net Debt | -183M -157M -144M -137M -252M -17.56B -256M -1.73B -668M -8.33B -687M -672M -29.04B | -143M -123M -112M -107M -196M -13.69B -200M -1.35B -521M -6.5B -536M -524M -22.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 1.720 $ | -4.97% | 2,750,157 |
| 14/05/26 | 1.810 $ | +17.53% | 6,941,912 |
| 13/05/26 | 1.540 $ | +6.94% | 2,503,089 |
| 12/05/26 | 1.440 $ | -3.36% | 4,347,714 |
| 11/05/26 | 1.490 $ | -0.67% | 5,659,507 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ENGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition